EIKCS 2022: Novel combination therapy shows promise in advanced kidney cancer
A combination therapy with a new targeted therapy (tyrosine kinase [...]
A combination therapy with a new targeted therapy (tyrosine kinase [...]
The results from a recent phase 2 trial looked at [...]
Previously, researchers found some genes that helped identify which patients [...]
Researchers are interested in the bacteria in our gut (the [...]
This phase 1 clinical trial looked at the safety, tolerability, [...]
Combination therapies have revolutionised the first-line treatment of metastatic clear [...]
Results from the NeoAvAx clinical trial were presented at the [...]
The National Institute for Health and Care Excellence (NICE) has [...]
Ongoing results from the phase 3 CheckMate-9ER clinical trial with nivolumab plus cabozantinib have been [...]
Results from the IMmotion151 phase III clinical trial were published [...]